Jonathan Gardner
@byjongardner.bsky.social
Senior reporter, BioPharma Dive
#MRK acknowledges $200 million in "costs related to tariffs
implemented to date," knocks a half-percentage point off gross margin guidance.
implemented to date," knocks a half-percentage point off gross margin guidance.
April 24, 2025 at 12:26 PM
#MRK acknowledges $200 million in "costs related to tariffs
implemented to date," knocks a half-percentage point off gross margin guidance.
implemented to date," knocks a half-percentage point off gross margin guidance.
One of the $LLY pipeline removals was volenrelaxin for heart failure (very bottom rectangle). Longtime #biotech watchers will remember that $NVS worked for years on a recombinant relaxin in heart failure before they decided to prioritize Entresto. Someday, a drugmaker will crack the relaxin puzzle.
February 6, 2025 at 2:20 PM
One of the $LLY pipeline removals was volenrelaxin for heart failure (very bottom rectangle). Longtime #biotech watchers will remember that $NVS worked for years on a recombinant relaxin in heart failure before they decided to prioritize Entresto. Someday, a drugmaker will crack the relaxin puzzle.
RFK: "Almost nothing is studied at NIH about the etiology of our chronic disease epidemic."
NIH:
NIH:
January 29, 2025 at 5:30 PM
RFK: "Almost nothing is studied at NIH about the etiology of our chronic disease epidemic."
NIH:
NIH: